Uppsala, 75185, Sweden
NCT Number: NCT01321814
Cognitive Behavioral Therapy for Hyperacusis
The main purpose of this study is to investigate whether cognitive behaviour therapy (CBT) can be useful for people suffering from Hyperacusis.
Also, the investigators are interested in investigating this group of patients on psychiatric and somatic comorbidity, personality traits, and startle response to sounds.
The investigators will also study the audiological measures commonly used in Sweden to measure hyperacusis, and investigate their validity.
The investigators hypothesize that CBT might be helpful for patients suffering from Hyperacusis.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
Hyperacusis, defined as unusual intolerance to ordinary environmental sounds, is a common problem for which there are no controlled trials on psychological treatment. Given the avoidance strategies present in hyperacusis, and similarities with problems such as tinnitus and chronic pain, cognitive behaviour therapy (CBT) is hypothesized to be helpful for patients with hyperacusis. In this randomized controlled study of 60 patients with hyperacusis, CBT was compared with a waiting list control group using the Loudness Discomfort Level test (LDL), the Hyperacusis Questionnaire, the Hospital Anxiety and Depression Scales, the Quality of Life Inventory and an adapted version of the Tampa Scale of Kinesiophobia. There were significant between-group effects in favour of the CBT group on all measures except for the HADS anxiety scale. Between-group effect sizes were moderate to high, with Cohen's d = 0.67 and 0.69 per ear, respectively, for the primary measure LDL, and ranging from d = 0.32 to 1.36 for the secondary measures. The differences between groups ceased to exist when the waiting list group was treated later with CBT, and the treatment results were largely maintained after 12 months. In conclusion, CBT is a promising treatment for hyperacusis, although more research is necessary.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient understands and can speak Swedish well
- Hyperacusis is the primary audiological problem
- Loudness discomfort thresholds below 90 dB
- Hearing levels better than 40dB on the best ear
- Resident of Uppsala, Stockholm or Vastmanland
- Possibility to travel to Uppsala or Vasteras for examination and treatment
Exclusion criteria
- Scoring "moderate" or "high" on suicidality, according to M.I.N.I
- Moderate to severe depression
- Psychotic disorders
Treatment and study plan
Cognitive Behavioural Therapy
Behavioral6 sessions by licensed psychologist, including psychoeducation, exposure therapy, applied relaxation and behavioral activation.
Primary outcomes
-
Quality of Life Inventory (QOLI)
Time frame: Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
Inventory measuring how patients' percieve the importance of and their satisfaction with many variables that concludes life quality, for instance economy, physical health and family life.
-
Khalfa Hyperacusis Questionnaire
Time frame: Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
A questionnaire to quantify and evaluate various hyperacusis symptoms, screening several aspects of auditory symptomatology.
-
Loudness discomfort threshold
Time frame: Time Frame: (FDAAA) Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
Audiological measure where the patient is exposed to sounds, gradually of higher volume. The patient is instructed to indicate when the sound level is uncomfortably loud, and that terminates the exposure. The test is performed by an audiologist using a calibrated audiometer.
Secondary outcomes
-
The Mini-International Neuropsychiatric Interview (M.I.N.I)
Time frame: At evaluation for participance (day one)
M.I.N.I is a short structured diagnostic interview (Sheehan et al, 1998), developed to detect DSM-IV and ICD-10 psychiatric disorders and was performed to investigate psychiatric comorbidity in this study. The Swedish version, 5.0.0. was used.
-
Swedish universities Scales of Personality (SSP)
Time frame: At evaluation for participance (day one)
SSP aims to measure personality correlates as well as biological correlates of some psychiatric disorders in order to define vulnerability factors (Gustavsson et al, 2000). The test consists of 13 scales, for instance somatic trait anxiety, psychic trait anxiety and stress susceptibility.
-
Tampa scale of Kinesiophobia - for Hyperacusis
Time frame: Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
TSK is a questionnaire used to measure fear of movement or reinjury in chronic pain patients. For this study, we adapted TSK for Hyperacusis patients.
-
Startle-response
Time frame: Evaluation for participance (day one), before treatment for waiting list patients (up to
Heart rate and skin conductance measured in response to sounds, in level with LDL:s.
Sponsors and collaborators
Lead sponsor
Linkoeping University
Other Gov
Collaborators
- Uppsala University
- Uppsala University Hospital
Registry information
Important dates
- Study start
- 2004
- Primary completion
- 2010
- Study completion
- 2012
- First posted
- Mar 24, 2011
- Registry last updated
- May 28, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Biomodulator Patch for Subjective Tinnitus
NCT07731230
Ear Diseases, Hearing Disorders
Istanbul, Kadikoy, Turkey (Türkiye)
View Trial DetailsExploratory Study on the Role of Somatic Modulation in Hyperacusis
NCT04693819
Ear Diseases, Hearing Disorders
Antwerp, Belgium
View Trial DetailsExposure Therapy for Auditory Sensitivity in Autism
NCT03206996
Autism, Autism Spectrum Disorder
Gainesville, Florida, United States
View Trial DetailsIntervention for Reduced Sound Tolerance
NCT00890526
Ear Diseases, Hearing Disorders
Baltimore, Maryland, United States
View Trial Details